Sunday at ESC Congress 2011

Updated:Sep 1,2011

ESC11_WebMasthead_600px

ESC Daily Recap: Sunday, August 28, 2011

Hotline I - Cardiovascular risk and complications
 esc11_ss_purePURE
The prevention gaps in 17 low-, middle-, and high-income countries involving over 150,000 people  
Salim Yusuf, McMaster University, Hamilton, ON
Presentation slides   |   Summary slide
 esc11_ss_hcsHCS
Prospective evaluation of postprandial triglycerides and cardiovascular events in patients with coronary artery disease  
Ulrich Laufs, Universitätskliniken des Saarlandes, Homburg/Saar, Germany
Summary slide
 esc11_ss_dalvesseldal-VESSEL
Efficacy and safety of dalcetrapib in patients with or at risk of coronary heart disease  
Thomas Lüscher, University Zurich, Switzerland
Summary slide
 esc11_aristotle-main_granger-4

ARISTOTLE
Efficacy and safety of apixaban compared with warfarin for prevention of stroke and systemic embolism in 18 202 patients with atrial fibrillation: Primary results  
Christopher Granger, Duke University, Durham, NC
Presentation slides   |   Summary slide   |   MedPage Today article
Interview with Elliott Antman, MD, FAHA (MedPage Today)

 esc11_ss_corpCORP
Colchicine for Recurrent Pericarditis: A multicenter, double-blind, randomized, controlled trial  
Massimo Imazio, Maria Vittoria Hospital, Turin, Italy
Summary slide


Clinical Trial Update I - Drug treatment
esc11_ascot_sever-8 ASCOT
Anglo-Scandinavian Cardiac Outcomes Trial: 10 year follow-up of the Lipid_lowering Arml   
Professor Peter S Sever, Imperial College, London, GB 
Presentation slides
 esc11_aristotle-ttr_wallentin-4ARISTOTLE
Efficacy and safety of Apixaban compared to Warfarin at different levels of INR control for stroke prevention in 18,202 patients with atrial fibrillation in the ARISTOTLE trial  
Lars C. Wallentin, Uppsala, Sweden
Presentation slides  
 esc11_rocket-af_fox-6ROCKET AF
Prevention of stroke and systemic embolism using the oral direct factor Xa inhibitor Rivaroxaban compared with Warfarin in patients with nonvalvular atrial fibrillation and moderate renal impairment   
Keith AA Fox, Edinburgh, Great Britain
Presentation slides

 


 


 

 


Understanding Clinical Trial Design a...

Welcome to ESC 2011

Become A Member

Become a professional member of the American Heart Association/American Stroke Association.

Join or renew your AHA/ASA Professional Membership
to qualify for members-only awards, and:

• Affiliate with one of 16 Scientific Councils.
• Save on AHA/ASA Scientific Sessions.
• Save on print publications.
• Apply for research funding and not pay a fee
• Enjoy many more membership benefits.

Promo code: WDJ008ZZ